Eric Lefebvre, Chief Medical Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 25,000 shares at $26.17 ($664K) on 2020-12-18, disclosed to the SEC on 2020-12-21.
Open-market sale of $664k PLRX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.17 | 6,788 | $178K | 26.8% |
| 2 | $26.17 | 6,788 | $178K | 26.8% |
| 3 | $26.98 | 5,712 | $154K | 23.2% |
| 4 | $26.98 | 5,712 | $154K | 23.2% |
| Total | $26.54 avg | 25,000 | $664K | 100% |
| Filing → |
| PLRX | SELL | 2024-01-19 | $355K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $804K | — | Filing → |
| PLRX | SELL | 2023-04-03 | $596K | — | Filing → |